Study across 8 European countries demonstrates feasibility of screening children for type 1 diabetes

New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), reports on pilot screening programs for type 1 diabetes in eight countries. The authors—a consortium including Dr. Peter Achenbach and professor Anette-Gabriele Ziegler from the Institute of Diabetes Research, Helmholtz Munich, Munich, Germany—say that screening should be rolled out across Europe, ideally with three testing windows: ages 2–4, 6–8 and 10–15.

Read it at Medical Xpress ↗

← Front page